Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -18.9040.1821.22112.252.74

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is -18.90 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-18.90
Mar202340.18
Mar202221.22
Mar2021112.25
Mar20202.74

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25
3,996.72
Mar2020 2.74 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,574.7 Cr 2.6% 0.5% 75% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,865.0 Cr -0.5% -8.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹173,574.0 Cr -2.4% 7.2% 50.6% Stock Analytics
CIPLA ₹118,710.0 Cr -0.7% -3.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,964.0 Cr -1.4% -3.9% 19% Stock Analytics
DR REDDYS LABORATORIES ₹104,232.0 Cr 0.5% 5.6% 5.1% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

2.6%

0.5%

75%

SENSEX

-1%

1.4%

7.9%


You may also like the below Video Courses